Lactic Acidosis - Causes, Resuscitation, and Workup

Key Points

• Elevated lactate is a physiologic marker, not a diagnosis of sepsis.
• Type A mechanisms involve impaired oxygen delivery or severe demand; type B mechanisms include drugs, seizures, liver dysfunction, malignancy, and thiamine deficiency.
• Mixed mechanisms are common.
• Treat the cause of lactate production and impaired clearance.
• Avoid indiscriminate fluid loading solely to normalize lactate.
• Regional ischemia requires urgent source treatment.
• Consider thiamine in malnourished patients with unexplained lactate elevation.
• Lactate trends should be interpreted alongside perfusion and organ function.

Algorithm

1. Confirm lactate elevation and assess hemodynamics, oxygenation, perfusion, and acid-base status.
2. Search rapidly for sepsis, hemorrhage, cardiogenic/obstructive shock, ischemia, seizure, drugs, and toxins.
3. Restore oxygen delivery and circulation according to the shock phenotype.
4. Provide source control or procedural treatment for infection or ischemia.
5. Stop causative drugs/toxins and give thiamine when deficiency is plausible.
6. Use dialysis for selected severe toxin/drug-associated or renal-failure cases.
7. Trend lactate and other perfusion markers.
8. Avoid treating the laboratory value in isolation once clinical perfusion is adequate.

Clinical Synopsis & Reasoning

Lactate is produced continuously and rises when production exceeds clearance. Type A patterns result from inadequate tissue oxygen delivery or utilization during shock, severe hypoxemia, major anemia, cardiac arrest, or regional ischemia. Type B patterns occur without obvious systemic hypoperfusion and include seizures, beta-agonists, epinephrine, metformin accumulation, malignancy, liver dysfunction, thiamine deficiency, mitochondrial toxins, and other conditions. The type A/type B distinction is useful conceptually but mixed mechanisms are common.

An elevated lactate is a risk marker, not a diagnosis of sepsis. Evaluate vital signs, perfusion, mental status, urine output, oxygenation, hemoglobin, cardiac function, infection, abdominal or limb ischemia, seizure activity, and medication/toxin exposure. A patient with normal blood pressure can still have poor perfusion, while a high lactate after a generalized seizure can fall rapidly without shock treatment. Beta-agonists and epinephrine can elevate lactate despite improving airflow or hemodynamics.

Liver dysfunction can reduce lactate clearance, but severe persistent elevation should not automatically be attributed to the liver without considering ongoing production. Metformin-associated lactic acidosis usually occurs in the setting of significant drug accumulation and physiologic stress, often kidney failure, rather than routine therapeutic use with stable renal function. Thiamine deficiency can cause or contribute to otherwise unexplained lactate elevation, especially with malnutrition or alcohol-use disorder.

Treatment Strategy & Disposition

Treat shock physiology immediately. Control hemorrhage, treat sepsis with appropriate antimicrobials and source control, restore circulation with fluids and vasoactive support based on hemodynamics, correct severe hypoxemia, and address cardiogenic or obstructive shock specifically. Do not give unlimited crystalloid simply because lactate is high; reassess perfusion and fluid responsiveness to avoid edema. Regional ischemia such as mesenteric ischemia or limb ischemia requires urgent procedural treatment.

Stop causative drugs or toxins and involve toxicology or nephrology when extracorporeal therapy may be needed. In severe metformin-associated lactic acidosis with kidney failure, shock, or profound acidemia, dialysis can remove metformin and correct acid-base abnormalities. Give thiamine empirically when deficiency is plausible because it is low risk and delayed treatment can prolong lactate production. Seizure-associated lactate should decline after seizure control; failure to clear warrants another cause search.

Trend lactate in context. A falling value can support improving perfusion, but resuscitation should not chase complete normalization with harmful fluid or catecholamine therapy. Capillary refill, skin temperature, urine output, blood pressure, mentation, bedside ultrasound, and organ function provide complementary information. Bicarbonate does not treat lactate production and is not routine therapy solely for an elevated lactate; selected severe acidemia may justify buffer or renal replacement strategies under disease-specific guidance.

Epidemiology / Risk Factors

• Lactate elevation is common in sepsis, shock, seizures, and critical illness.
• Higher and persistent levels generally correlate with greater illness severity.
• Medication-related elevations are common in emergency and ICU settings.
• Clearance is influenced by liver and kidney function as well as production.

Investigations

Common Contributors

Pharmacology

Prognosis / Complications

• Prognosis depends on cause and persistence.
• Rapid postictal elevations often normalize quickly.
• Persistent lactate in shock signals ongoing high risk.
• Correctable causes such as thiamine deficiency or medication effect can improve dramatically when recognized.

Patient Education / Counseling

• Explain that lactate is a marker pointing to physiologic stress, not a disease itself.
• Patients taking metformin should follow sick-day and kidney-function guidance from their diabetes team.
• Seek urgent care for signs of shock, severe infection, or ischemic pain.
• Patients with heavy alcohol use or malnutrition should discuss thiamine and nutrition support.
• After recovery, review the precipitating illness and medication changes needed to prevent recurrence.

Notes

A lactate target should never replace a perfusion assessment. If blood pressure, capillary refill, urine output, mental status, and cardiac filling suggest adequate circulation, continuing liters of fluid to force lactate to normal can cause harm. Ask why lactate is being produced or not cleared, then treat that mechanism.

References

1. ADA/EASD/JBDS/AACE/DTS: 2024 Consensus Report on Hyperglycemic Crises in Adults With Diabetes — Link
2. KDIGO: Potassium Management Controversies Conference — Link
3. KDIGO: 2024 Clinical Practice Guideline for Evaluation and Management of CKD — Link